State of Wyoming Purchases 2,573 Shares of Cigna Group $CI

State of Wyoming boosted its position in shares of Cigna Group (NYSE:CI) by 1,383.3% during the 4th quarter, HoldingsChannel reports. The fund owned 2,759 shares of the health services provider’s stock after buying an additional 2,573 shares during the quarter. State of Wyoming’s holdings in Cigna Group were worth $759,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Providence Capital Advisors LLC increased its stake in Cigna Group by 1,016.8% during the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after acquiring an additional 7,748 shares during the period. Caprock Group LLC acquired a new stake in Cigna Group during the third quarter valued at approximately $4,124,000. Banco Bilbao Vizcaya Argentaria S.A. boosted its holdings in Cigna Group by 13.5% during the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock valued at $9,839,000 after purchasing an additional 4,066 shares in the last quarter. Compass Wealth Management LLC acquired a new stake in Cigna Group during the third quarter valued at approximately $4,718,000. Finally, Varma Mutual Pension Insurance Co boosted its holdings in Cigna Group by 9.6% during the third quarter. Varma Mutual Pension Insurance Co now owns 40,942 shares of the health services provider’s stock valued at $11,802,000 after purchasing an additional 3,600 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Cigna Group Stock Up 3.7%

Shares of CI opened at $280.86 on Friday. The company has a market capitalization of $74.30 billion, a P/E ratio of 11.91, a PEG ratio of 1.04 and a beta of 0.28. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The business’s 50 day simple moving average is $279.18 and its 200-day simple moving average is $277.15.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s payout ratio is presently 26.45%.

Analyst Ratings Changes

A number of research firms have weighed in on CI. The Goldman Sachs Group lifted their price objective on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Leerink Partners lifted their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. UBS Group lifted their price objective on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Finally, Truist Financial lifted their price objective on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $338.30.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.